Cyclerion Therapeutics Inc [NASDAQ: CYCN] jumped around 1.38 points on Monday, while shares priced at $3.92 at the close of the session, up 54.33%.
Compared to the average trading volume of 3.25M shares, CYCN reached a trading volume of 82349284 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Cyclerion Therapeutics Inc [CYCN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CYCN shares is $80.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CYCN stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Cyclerion Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 20, 2021. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on September 24, 2021, representing the official price target for Cyclerion Therapeutics Inc stock.
The Average True Range (ATR) for Cyclerion Therapeutics Inc is set at 0.50, with the Price to Sales ratio for CYCN stock in the period of the last 12 months amounting to 55.89. The Price to Book ratio for the last quarter was 1.21, with the Price to Cash per share for the same quarter was set at 1.06.
How has CYCN stock performed recently?
Cyclerion Therapeutics Inc [CYCN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 46.27. With this latest performance, CYCN shares gained by 13.62% in over the last four-week period, additionally plugging by 17.37% over the last 6 months – not to mention a rise of 6.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CYCN stock in for the last two-week period is set at 64.16, with the RSI for the last a single of trading hit 72.07, and the three-weeks RSI is set at 59.54 for Cyclerion Therapeutics Inc [CYCN]. The present Moving Average for the last 50 days of trading for this stock 2.99, while it was recorded at 2.80 for the last single week of trading, and 2.87 for the last 200 days.
Cyclerion Therapeutics Inc [CYCN]: Deeper insight into the fundamentals
Cyclerion Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.07 and a Current Ratio set at 5.07.
Insider trade positions for Cyclerion Therapeutics Inc [CYCN]
There are presently around $40.41%, or 51.74%% of CYCN stock, in the hands of institutional investors.
